Clinical Pharmacology and Therapeutics of Hypertension, Handbook of Hypertension Series

Clinical Pharmacology and Therapeutics of Hypertension

Handbook of Hypertension Series

By Gordon McInnes, BSc, MD, FRCP, FFPM, FAHA, Division of Cardiovascular and Medical Sciences, Gardiner Institute, Western Infirmary, Glasgow, UK

Section I: General considerations:

Classification of antihypertensive drugs and pharmacological considerations. Interaction of antihypertensive drugs with mechanisms of blood pressure regulation. Antihypertensive drugs: pharmacokinetics, pharmacodynamics, metabolism, side effects and drug interactions. Antihypertensive drugs: hemodynamic effects.

Section II: Diuretics:

Thiazides and loop diuretics. Aldosterone antagonists

Section III: Centrally acting drugs:

Methyldopa and imidazolone agonists.

Section IV: Vasodilator drugs:

Alpha-blocking drugs. Calcium channel blockers. Potent vasodilators.

Section V: Beta-blocking agents:

Beta-adrenoceptor blocking drugs.

Section VI: Drugs acting on the renin-angiotensin system:

Angiotensin converting enzyme inhibitors. Angiotensin receptor blockers. Vasopeptidase inhibitors.

Section VII: Future prospects:

Novel agents in development.

Section VIII: Clinical trials:

The evidence-base for treatment of hypertension.

Section IX: Therapeutic strategies:

Combination therapy. Sequential monotherapy.

Section X: Special patient groups:

Pregnancy. The elderly. Hypertension and diabetes. Ethnic considerations in hypertension.